Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokersSOFUOGLU, Mehmet; BABB, David; HATSUKAMI, Dorothy K et al.Nicotine & tobacco research. 2003, Vol 5, Num 6, pp 947-953, issn 1462-2203, 7 p.Article

LABETALOL IN CONTROLLED HYPOTENSION. ADMINISTRATION OF LABETALOL WHEN ADEQUATE HYPOTENSION IS DIFFICULT TO ACHIEVECOPE DHP; CRAWFORD MC.1979; BRIT. J. ANAESTH.; GBR; DA. 1979; VOL. 51; NO 4; PP. 359-365; ABS. FRE/GER/SPA; BIBL. 27 REF.Article

Suspected β-antagonist-induced thrombocytopeniaSTAMM, Pamela L; JENKINS, J. Kimble; VIGRASS, Howard G et al.The Annals of pharmacotherapy. 2005, Vol 39, Num 3, pp 555-558, issn 1060-0280, 4 p.Article

Statistical moments for placental transfer of solutes in manBERNUS, I; ROBERTS, M. S; RASIAH, R. L et al.Journal of pharmacy and pharmacology. 1999, Vol 51, Num 12, pp 1381-1389, issn 0022-3573Article

Stereospecific gas chromatographic/mass spectrometric assay of the chiral labetalol metabolite 3-amino-1-phenylbutaneCHANGCHIT, A; GAL, J; ZIRROLLI, J. A et al.Biological mass spectrometry. 1991, Vol 20, Num 12, pp 751-758Article

Divergent effects of different beta-blocking agents on endothelium-dependent vasodilatation in the human forearmVON ZUR MÜHLEN, B; MILLGARD, J; LIND, L et al.Blood pressure. 2000, Vol 9, Num 5, pp 287-292, issn 0803-7051Article

Multivariate calibration on designed mixtures of four pharmaceuticalsDEMIR, C; BRERETON, R. G.Analyst (London. 1877. Print). 1998, Vol 123, Num 2, pp 181-189, issn 0003-2654Article

Effect of antihypertensive agents on the arterial partial pressure of oxygen and venous admixture after cardiac surgeryWOOD, G.Critical care medicine. 1997, Vol 25, Num 11, pp 1807-1812, issn 0090-3493Article

BLUTDRUCKSENKUNG MIT DEM KOMBINIERTEN ALPHA-BETA-REZEPTORENBLOCKER LABETALOL IN DER RHINOCHIRUGIE = HYPOTENSION AVEC LE LABETALOL UN ALPHA ET BETA BLOQUANT COMBINE EN CHIRUGIE DU NEZPASCH T; PINGEL I.1982; ANAESTH., INTENSIVTH., NOTFALLMED.; ISSN 0174-1837; DEU; DA. 1982; VOL. 17; NO 2; PP. 74-77; ABS. ENG; BIBL. 10 REF.Article

CIRCULATORY EFFECTS OF LABETALOL DURING HALOTHANE ANAESTHESIA.SCOTT DB; BUCKLEY FP; LITTLEWOOD DG et al.1978; ANAESTHESIA; G.B.; DA. 1978; VOL. 33; NO 2; PP. 145-156; BIBL. 9 REF.Article

Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patientsCARVALHO, Teresa Maria J. P; DE CARVALHO CAVALLI, Ricardo; CUNHA, Sérgio P et al.European journal of clinical pharmacology. 2011, Vol 67, Num 1, pp 55-61, issn 0031-6970, 7 p.Article

CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjectsWA CHAN, Sze; MIAO HU; SHUN WAH KO, Sara et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 799-806, issn 0031-6970, 8 p.Article

Severe hypertension in pregnancy : Hydralazine or labetalol A randomized clinical trialVIGIL-DE GRACIA, Paulino; LASSO, Martin; RUIZ, Esteban et al.European journal of obstetrics, gynecology, and reproductive biology. 2006, Vol 128, Num 1-2, pp 157-162, issn 0301-2115, 6 p.Article

Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalolDOMENIGHETTI, G. M; SAVARY, G; STRICKER, H et al.British medical journal (1857). 1984, Vol 288, Num 6429, pp 1483-1484, issn 0007-1447Article

The quantal secretion of catecholamines is impaired by the accumulation of β-adrenoceptor antagonists into chromaffin cell vesiclesMONTESINOS, Mónica S; CAMACHO, Marcial; MACHADO, J. David et al.British journal of pharmacology. 2010, Vol 159, Num 7, pp 1548-1556, issn 0007-1188, 9 p.Article

CHANGES IN FETAL AND MATERNAL DOPPLER PARAMETERS OBSERVED DURING ACUTE SEVERE HYPERTENSION TREATMENT WITH HYDRALAZINE OR LABETALOL: A RANDOMIZED CONTROLLED TRIALBAGGIO, Maria Rita F; MARTINS, Wellington P; CALDERON, Ana Carolina S et al.Ultrasound in medicine & biology. 2011, Vol 37, Num 1, pp 53-58, issn 0301-5629, 6 p.Article

Use of Antihypertensive Drugs during Pregnancy and LactationGHANEM, Firas A; MOVAHED, Assad.Cardiovascular therapeutics (Print). 2008, Vol 26, Num 1, pp 38-49, issn 1755-5914, 12 p.Article

Adverse neonatal effects of maternal labetalol treatmentCROOKS, B. N. A; DESHPANDE, S. A; HALL, C et al.Archives of disease in childhood. Fetal and neonatal edition. 1998, Vol 79, Num 2, pp F150-F151, issn 1359-2998Article

Les antihypertenseurs de l'urgence : Pharmacologie et utilisation pratique = Urgent antihypertensive drugs : Pharmacology and practice useKASTALLI, S; DAGHFOUS, R; BELKAHIA, C et al.Maghreb médical. 1999, Num 340, pp 16-17, issn 0330-258XArticle

Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluidsDAKERS, J. M; BOULTON, D. W; FAWCETT, J. P et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 704, Num 1-2, pp 215-220, issn 1387-2273Article

Les thérapeutiques obstétricales. Les anti-hypertenseurs = Obstetrical therapy. AntihypertensivesFOURNIE, A.Contraception, fertilité, sexualité (1991). 1999, Vol 27, Num 10, pp 662-669, issn 1157-8181Article

Protective effects of labetalol on myocardial contractile function in brain-dead pigsSIAGHY, E. M; HALEJCIO-DELOPHONT, P; DEVAUX, Y et al.Transplantation proceedings. 1998, Vol 30, Num 6, pp 2842-2843, issn 0041-1345Conference Paper

Studies on the photostability and in vitro phototoxicity of LabetalolANDRISANO, Vincenza; BALLARDINI, Roberto; HRELIA, Patrizia et al.European journal of pharmaceutical sciences. 2001, Vol 12, Num 4, pp 495-504, issn 0928-0987Article

Gender differences in labetalol kinetics : Importance of determining stereoisomer kinetics for racemic drugsJOHNSON, J. A; AKERS, W. S; HERRING, V. L et al.Pharmacotherapy. 2000, Vol 20, Num 6, pp 622-628, issn 0277-0008Article

LABETALOL IN LONG-TERM TREATMENT OF MEDIUM-SEVERE ARTERIAL HYPERTENSION: CLINICAL STUDYSALVADEO A; VILLA G; SEGAGNI S et al.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 31; NO 2; PP. 209-218; BIBL. 16 REF.Article